Medical Malpractice Screening Panels
Medical malpractice screening panels are state-established procedural mechanisms that require prospective plaintiffs to submit a malpractice claim to a review body before filing suit in civil court. These panels evaluate whether the evidence supports a finding that the applicable standard of care was breached, functioning as a gatekeeping layer between the claimant and the litigation system. Their scope, composition, and binding effect vary significantly across the states that maintain them, making them a central feature of the pre-suit requirements in medical malpractice landscape.
Definition and scope
A medical malpractice screening panel — also termed a prelitigation panel, medical review panel, or tribunal — is a quasi-judicial or administrative body convened to assess the threshold merit of a malpractice claim before that claim proceeds to formal litigation. The defining characteristic is procedural interposition: the panel sits between the claimant's notice of injury and the filing of a civil complaint.
Approximately 20 states have enacted some form of mandatory pre-litigation review panel by statute, though the specific mechanisms differ substantially. States including Indiana, Louisiana, and Utah operate formal Medical Review Panels under dedicated statutory frameworks. Indiana's Medical Malpractice Act (Indiana Code § 34-18) requires all claims against qualified healthcare providers to pass through a three-member medical review panel before a court complaint may be filed. Louisiana's Medical Malpractice Act (Louisiana Revised Statutes § 40:1231.1 et seq.) similarly mandates panel review and caps liability at $500,000 for providers enrolled in the Patients' Compensation Fund (Louisiana PCF).
The scope of these panels typically extends to licensed physicians, hospitals, and allied health professionals, though the exact class of covered providers is defined by each state's enabling statute. Claims involving government healthcare providers may fall outside state panel jurisdiction and instead proceed under the Federal Tort Claims Act.
How it works
The procedural sequence for a medical malpractice screening panel follows a recognizable structure across jurisdictions, even though specific timelines and compositions differ:
- Notice of Claim Filing — The claimant submits a formal notice of claim to the designated state administrative body or tribunal clerk, identifying the healthcare provider, the alleged injury, and the factual basis. This filing tolls the applicable statute of limitations in most states that require panels.
- Panel Composition — A panel is assembled, commonly consisting of one or more licensed physicians in the relevant specialty and, in attorney-model states, one or more attorneys or a retired judge. Indiana's panels use one attorney and three physicians. Virginia formerly used a combination of attorneys and medical professionals before restructuring its system in 1999.
- Evidence Submission — Both parties submit written materials: medical records, expert opinions, and supporting documentation. Panels generally do not conduct live testimony hearings in the same manner as trials; review is predominantly documentary.
- Panel Opinion — The panel issues a written opinion on whether the evidence supports a conclusion that the defendant breached the applicable standard of care and whether that breach caused the claimed damages. This is an expert-level assessment, not a judicial verdict.
- Effect on Litigation — In most states the panel's opinion is not binding on the court but is admissible as evidence. In states such as Indiana, the panel opinion may be introduced at trial by either party. In Maine's tribunal model, a finding against the plaintiff requires posting a bond to proceed to court.
The expert witness requirements that govern trial testimony also shape the qualifications of physician panelists; states typically require panelists to hold active licensure in the same or a substantially similar specialty as the defendant provider.
Common scenarios
Screening panels arise across the full range of malpractice claim types. Representative scenarios include:
- Surgical complications — A patient alleges that a retained surgical instrument caused post-operative infection. The panel reviews operative notes and expert opinions to assess whether the surgical team met the applicable standard. This intersects directly with surgical malpractice claims.
- Diagnostic failure — A claimant asserts that a failure to order imaging resulted in delayed cancer diagnosis. The panel evaluates whether the ordering decision fell below what a competent practitioner would have done. See misdiagnosis and delayed diagnosis malpractice.
- Birth injuries — Claims involving obstetric care, including shoulder dystocia or hypoxic events during delivery, are submitted to the panel with fetal monitoring strips and labor records. Birth injury malpractice claims are among the highest-value matters that pass through panel review.
- Medication errors — Prescribing or dispensing errors that result in patient harm require panel evaluation of whether the prescribing decision conformed to established protocols, relevant to medication error malpractice claims.
Decision boundaries
The critical distinction separating screening panel models is whether the panel's opinion carries binding or non-binding effect:
| Model | Binding Effect | States (Examples) |
|---|---|---|
| Advisory/Non-binding | Opinion admissible but not conclusive | Indiana, Louisiana |
| Bond-requirement | Adverse finding requires plaintiff to post bond | Maine |
| Mandatory but non-enforceable | Opinion issued; no penalty for ignoring it | Kansas (pre-2010) |
A second classification boundary involves the constitutional treatment of these panels. State supreme courts in Illinois and Ohio have struck down mandatory screening panel requirements as violations of state constitutional access-to-courts provisions, and malpractice caps constitutionality litigation has proceeded along parallel tracks in multiple jurisdictions. The National Conference of State Legislatures (NCSL) tracks the status of screening panel statutes as part of its medical malpractice tort reform surveys.
A third boundary concerns the relationship between panel findings and the National Practitioner Data Bank. Panel opinions, unlike judgments and settlements, are not reportable events under the Health Care Quality Improvement Act of 1986 (42 U.S.C. § 11101 et seq.) and do not trigger Data Bank reporting obligations. A settlement reached after a panel finding, however, is reportable.
Panels also operate within the broader framework of medical malpractice tort reform, and states that have repealed their panel requirements often cite delays — Indiana's review process can extend 18 months — as undermining the efficiency rationale that justified the mechanism.
References
- Indiana Medical Malpractice Act — Indiana Code § 34-18
- Louisiana Medical Malpractice Act — Louisiana Revised Statutes § 40:1231.1 et seq.
- Louisiana Patients' Compensation Fund (PCF)
- National Conference of State Legislatures — Medical Malpractice Tort Reform
- Health Care Quality Improvement Act of 1986 — 42 U.S.C. § 11101 et seq.
- U.S. Department of Health & Human Services — National Practitioner Data Bank